Drugmakers will add price data to ads, but not as much as Trump wants

The pharmaceutical industry’s friendly relationship with the Trump administration since it introduced its blueprint to lower drug prices in May is now starting to show signs of strain. And it’s all about TV drug ads.

Source link

Leave a Comment

Novartis drug cut death risk by 35 percent in gene mutation breast cancer'Mad cow disease': What is BSE?